Larry Norton

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Topics

Brain Metastases

Neoadjuvant Chemotherapy

Locally Advanced

Top Venues

NPJ breast cancer

Annals of global health

JCO precision oncology

Research square

This page only lists publications with an associated author ORCID identifier.

Publications

Yonina R Murciano-Goroff, Angela B-Y Hui, Jose de Arimateia Batista Araujo-Filho, Emily G Hamilton, Jacob J Chabon, Everett J Moding, Rene F Bonilla, Emily S Lebow, Daniel Gomez, Andreas Rimner, Michelle S Ginsberg, Michael D Offin, Ritika Kundra, Viola Allaj, Larry Norton, Jorge S Reis-Filho, Pedram Razavi, Alexander E Drilon, David R Jones, James M Isbell, W Victoria Lai, Charles M Rudin, Ash A Alizadeh, Bob T Li, Maximillian Diehn
Early Circulating Tumor DNA Shedding Kinetics for Prediction of Platinum Sensitivity in Patients With Small Cell Lung Cancer. JCO precision oncology 8 (2024)
Yonina R Murciano-Goroff, Angela B-Y Hui, Jose de Arimateia Batista Araujo-Filho, Emily G Hamilton, Jacob J Chabon, Everett J Moding, Rene F Bonilla, Emily S Lebow, Daniel Gomez, Andreas Rimner, Michelle S Ginsberg, Michael D Offin, Ritika Kundra, Viola Allaj, Larry Norton, Jorge S Reis-Filho, Pedram Razavi, Alexander E Drilon, David R Jones, James M Isbell, W Victoria Lai, Charles M Rudin, Ash A Alizadeh, Bob T Li, Maximillian Diehn
Early Circulating Tumor DNA Shedding Kinetics for Prediction of Platinum Sensitivity in Patients With Small Cell Lung Cancer. JCO precision oncology 8 (2024)
Nicholas Mai, Sara Myers, Sherry Shen, Stephanie Downs-Canner, Mark E Robson, Larry Norton, Yuan Chen, Tiffany A Traina, Nour Abuhadra
Dose dense doxorubicin plus cyclophosphamide in a modified KEYNOTE522 regimen for triple negative breast cancer. NPJ breast cancer 10 (1) (2024)
Nicholas Mai, Sara Myers, Sherry Shen, Stephanie Downs-Canner, Mark E Robson, Larry Norton, Yuan Chen, Tiffany A Traina, Nour Abuhadra
Dose dense doxorubicin plus cyclophosphamide in a modified KEYNOTE522 regimen for triple negative breast cancer. NPJ breast cancer 10 (1) (2024)
Nicholas Mai, Carlos H Dos Anjos, Pedram Razavi, Anton Safonov, Sujata Patil, Yuan Chen, Joshua Z Drago, Shanu Modi, Jacqueline F Bromberg, Chau T Dang, Dazhi Liu, Larry Norton, Mark E Robson, Sarat Chandarlapaty, Komal L Jhaveri
Predictors of Response to CDK4/6i Retrial After Prior CDK4/6i Failure in ER+ Metastatic Breast Cancer. Research square (2024)
Komal L Jhaveri, Nicholas Mai, Carlos Henrique Dos Anjos, Pedram Razavi, Anton Safonov, Sujata Patil, Yuan Chen, Joshua Drago, Shanu Modi, Jacqueline Bromberg, Chau T Dang, Dazhi Liu, Larry Norton, Mark E Robson, Sarat Chandarlapaty
Predictors of Response to CDK4/6i Retrial After Prior CDK4/6i Failure in ER+ Metastatic Breast Cancer. Research square (2024)
Nicholas Mai, Sara Myers, Sherry Shen, Stephanie Downs-Canner, Mark E Robson, Larry Norton, Yuan Chen, Tiffany A Traina, Nour Abuhadra
Dose dense doxorubicin plus cyclophosphamide in a modified KEYNOTE522 regimen for triple negative breast cancer. NPJ breast cancer 10 (1) (2024)
Ghassan K Abou-Alfa, Larry Norton, null null
Global Oncology Medical Diplomacy Working Group Inaugural Meeting: Defining Worldwide Barriers to Germline Genomics in Cancer Prevention and Management. Annals of global health 89 (1) (2023)
Ghassan K Abou-Alfa, Larry Norton, null null
Global Oncology Medical Diplomacy Working Group Inaugural Meeting: Defining Worldwide Barriers to Germline Genomics in Cancer Prevention and Management. Annals of global health 89 (1) (2023)
Ghassan K Abou-Alfa, Larry Norton, null null
Global Oncology Medical Diplomacy Working Group Inaugural Meeting: Defining Worldwide Barriers to Germline Genomics in Cancer Prevention and Management. Annals of global health 89 (1) (2023)
Carmela Caballero, Alexandre Irrthum, Theodora Goulioti, David Cameron, Larry Norton, Martine J Piccart
International research to address the challenges of metastatic breast cancer: the AURORA Program (BIG 14-01). NPJ breast cancer 9 (1) (2023)
Zuen Ren, Huizhi Liang, Phillip M Galbo, Malindrie Dharmaratne, Ameya S Kulkarni, Atefeh Taherian Fard, Marie Louise Aoun, Nuria Martinez-Lopez, Kimita Suyama, Outhiriaradjou Benard, Wei Zheng, Yang Liu, Joseph Albanese, Deyou Zheng, Jessica C Mar, Rajat Singh, Michael B Prystowsky, Larry Norton, Rachel B Hazan
Redox signaling by glutathione peroxidase 2 links vascular modulation to metabolic plasticity of breast cancer. Proceedings of the National Academy of Sciences of the United States of America 119 (8) (2022)
Anne Grabenstetter, Edi Brogi, Hong Zhang, Pedram Razavi, Jorge Sergio Reis-Filho, Kimberly J VanZee, Larry Norton, Hannah Y Wen
Solid-basaloid variant of adenoid cystic carcinoma of the breast with near complete response to neoadjuvant chemotherapy. NPJ breast cancer 8 (1) (2022)
David B Page, Kathryn Beal, Stefanie N Linch, Kateri J Spinelli, Micaela Rodine, Darragh Halpenny, Shanu Modi, Sujata Patil, Robert J Young, Thomas Kaley, Taha Merghoub, David Redmond, Phillip Wong, Christopher A Barker, Adi Diab, Larry Norton, Heather L McArthur
Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/- trastuzumab in patients with breast cancer brain metastases. NPJ breast cancer 8 (1) (2022)
Martine J Piccart, Florentine S Hilbers, Judith M Bliss, Carmela Caballero, Elizabeth S Frank, Patrick Renault, Rachida Naït Kaoudjt, Eva Schumacher, Patricia A Spears, Meredith M Regan, Richard D Gelber, Nancy E Davidson, Larry Norton, Eric P Winer, null null
Road Map to Safe and Well-Designed De-escalation Trials of Systemic Adjuvant Therapy for Solid Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (34) (2020)
Mark P S Dunphy, Christina Pressl, Nagavarakishore Pillarsetty, Milan Grkovski, Shanu Modi, Komal Jhaveri, Larry Norton, Bradley J Beattie, Pat B Zanzonico, Danuta Zatorska, Tony Taldone, Stefan O Ochiana, Mohammad M Uddin, Eva M Burnazi, Serge K Lyashchenko, Clifford A Hudis, Jacqueline Bromberg, Heiko M Schöder, Josef J Fox, Hanwen Zhang, Gabriela Chiosis, Jason S Lewis, Steven M Larson
First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (19) (2020)